Find out which Small-Cap / Micro-Caps should be on your radar. Get the news and information that moves the markets this week and the "Ones to Watch", only at QualityStocks. The "Quality" is Back in Stocks...
American Oriental Bioengineering Inc. (AOB)
American Oriental Bioengineering, Inc. is a pharmaceutical company that lists on the New York Stock Exchange (NYSE). The Company's dedication is to improving health through the development, manufacture and commercialization of a wide array of prescription and over the counter products. American Oriental Bioengineering Inc.'s corporate vision is to be the global leader in modern plant-based pharmaceutical products.
The Company, in recent years, based on their R&D of plant-based pharmaceuticals (traditional Chinese medicine) and nutraceuticals, has also comprehensively developed the research & development of chemical and biological medicines. In 2008, they established the AOBO Research Institute in Beijing. They also set up research institutes (centers) in their proprietary companies throughout China. These include the Harbin Drug Research Institute, the Harbin Three Happiness Food Research Institute, the Hebei Aoxing Narcotics (painkiller) Development Center, the Guangxi Nanning Research Institute and the Guangxi Hezhou Lingfeng Pharmaceuticals Development Center.
Concurrently, AOBO built extensive and in-depth collaborative relationships with domestic renowned drug Research & Development Organizations, such as the Institute of Materia Medica at the ChineseAcademy of Medical Sciences (including the Institute of Medicinal Plant Development (IMPLAD), affiliated with the ChineseAcademy of Medical Sciences).
AOBO's principal prescription pharmaceutical products include Shuanghuanglian Lyophilized Injection Powder (SHL Injection Powder), an anti-viral injection for treating respiratory infections, bronchitis, and tonsillitis, and Cease Enuresis Soft Gel (CE Gel) used to alleviate bedwetting. Their over-the-counter (OTC) pharmaceutical products include Jinji Series, a line of products approved for the treatment of various women's health indications, including endometritis, annexitis, pelvic inflammation, and premenstrual and menopausal symptoms. OTC products also include Jinji Yimucao, used for the treatment of premenstrual syndrome and other PMS and menopause-related symptoms; Cease Enuresis Patch, a product indicated to alleviate bedwetting and for the treatment of incontinence; and Boke Series, a line of nasal products indicated to alleviate sinus infections and nasal congestions.
The QualityStocks Blog keeps investors up to date on everything related to the Small-Cap and Micro-Cap markets. By visiting our blog, investors also discover emerging companies that they otherwise would not have heard about.
The message boards here at QualityStocks is one of the most highly regulated, no-nonsense forums online today. Investors actively discuss their favorite trading ideas within the NYSE, NASDAQ, AMEX, OTCBB and Pink Sheets markets.
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
Meet The Team
Meet the team at QualityStocks.
Get your newsletter covered
by The QualityStocks Daily.
Become a sponsor of
The QualityStocks Daily.
Get your company featured
in The QualityStocks Daily.
|Submit Public Company Press Releases Press@QualityStocks.net|
|Submit Public Company News Releases News@QualityStocks.net|
Submit Resume Jobs@QualityStocks.net
See Job Descriptions
To submit a press release, share a story idea, or give us feedback, contact us.
Go back to see our previous newsletters and find out what you might have missed.